Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bayer Kogenate FS recall

Executive Summary

Bayer initiates recall of Kogenate FS and Aventis' Helixate FS after failure to meet potency specifications after nine weeks at room temperature. The recall, initiated Jan. 9, involves 10,000 vials. Bayer issued a similar recall in July 2000. Shipments of Kogenate FS were halted in March 2001 after FDA cited GMP violations (1"The Pink Sheet" March 26, 2001, p. 15)...

Bayer initiates recall of Kogenate FS and Aventis' Helixate FS after failure to meet potency specifications after nine weeks at room temperature. The recall, initiated Jan. 9, involves 10,000 vials. Bayer issued a similar recall in July 2000. Shipments of Kogenate FS were halted in March 2001 after FDA cited GMP violations (1 , p. 15)....

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039158

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel